Sign in
Explore the registryTrack Remibrutinib's trials

REMASTER

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

Remibrutinib (blinded)OngoingRecruitingPhase 3Open NCT07225504 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…